BMO Capital Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Cannot Defend the Specialty Pharmacy Structure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
Go back to BMO Capital Downgrades Valeant Pharmaceuticals (VRX) to Market Perform; Cannot Defend the Specialty Pharmacy Structure
October 21, 2015 7:35 PM EDT
AMSTERDAM--(BUSINESS WIRE)--
Pershing Square Holdings, Ltd. (ticker: PSH:NA) confirms media reports
that Pershing Square Capital Management purchased, on behalf of the
funds it manages, in excess of 2 million additional shares of Valeant
Pharmaceuticals International, Inc. (ticker: NYSE: VRX) on 21 October
2015.
About Pershing Square... More
October 21, 2015 2:31 PM EDT
WINDSOR, Ontario--(BUSINESS WIRE)--
Valeant Pharmaceuticals International Inc. (NYSE: VRX; TSX: VRX),
is being investigated by Sutts, Strosberg LLP, a law firm that
represents investors in securities class actions.
The firm is investigating the company in the wake of a report by Citron... More
October 21, 2015 1:39 PM EDT
LAVAL, Quebec, Oct. 21, 2015 /PRNewswire/ --Â Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today responded to recent accusations made regarding its financial reporting and operations.
Philidor Rx Services is a pharmacy licensed in Pennsylvania and also provides back-end services, including call center, claims adjudication, IT and logistics support, as well as compliance/HIPPA regulation guidance, to other pharmacies, including R&O Pharmacy. This includes a common call center phone number serviced by Philidor for the Philidor network pharmacies.Â
All...
More
